The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

In efforts to boost innovation, pharma and med-tech sectors in India seek a 10% allocation from the National Research Fund, ...

A longtime pharmaceutical executive laments the woeful state of the industry and calls for new leadership to win back public ...

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

A series of uncertainties that kept dealmaking to a minimum last year could be reversing as pharma reloads pipelines ahead of ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

IFF Pharma Solutions is a winner in the Marketing category in the 2024 Pharmaceutical Technology Excellence Awards.

As the J.P. Morgan Healthcare Conference enters its second day, we're tracking presentations from GSK, Novartis, Sanofi, Eli ...

BridgeBio Pharma stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 64 ...

New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry despite the uncertain macro environment. A strong portfolio and solid ...

Aurinia Pharmaceuticals (AUPH) released its third-quarter results, reporting solid revenue growth and robust cash flow from operations. Solid demand for its product offerings, restructuring strategies ...

Dividend growth investing is a powerful strategy for building lasting wealth. Companies that consistently raise their ...